'Net sales
(including other operating income) of Advanced Enzyme Technologies has
increased 5.93% to Rs 167.18 crore.
Operating profit margin has declined from 35.08% to 27.28%, leading to
17.64% decline in operating profit to Rs 45.60 crore. Raw material cost as a % of total sales (net
of stock adjustments) increased from 22.69% to 27.50%. Employee cost increased from 20.82% to
22.06%. Other expenses rose from 21.48%
to 23.13%.
The revenue
from human nutrition segment increased by 1% to Rs 1,031 million in Q4 FY25 as
compared to Rs 1,024 million in Q4 FY24
The Animal
nutrition delivered a growth of 13% to Rs 209 million in Q4 FY25 as against Rs
185 million in Q4 FY24
The
Bio-Processing segment grew by 8% during the quarter, it accounted for Rs 278
million in Q4 FY25 as compared to Rs 258...
Pleaselogin & subscribe to view the full report.
More Reports
-
(03-Aug-2025)
Federal Bank
High provisions drag bottom-line
-
(02-Aug-2025)
Epigral
Deferred tax liability benefit boosted profits
-
(02-Aug-2025)
JSW Energy
Net up 42% on good operating show
-
(02-Aug-2025)
NTPC
Sales down 3%, net up 10%
|
|